These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21930343)

  • 1. Efficacy and safety of intraoperative radiotherapy in breast cancer: a systematic review.
    Ruano-Ravina A; Cantero-Muñoz P; Eraso Urién A
    Cancer Lett; 2011 Dec; 313(1):15-25. PubMed ID: 21930343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
    BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative radiotherapy (IORT) versus whole-breast external beam radiotherapy (EBRT) in early stage breast cancer: results from SEER database.
    Lei J; Wang Y; Bi Z; Xue S; Ou B; Liu K
    Jpn J Radiol; 2020 Jan; 38(1):85-92. PubMed ID: 31691091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
    Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy.
    Elsberger B; Romsauerova A; Vinnicombe S; Whelehan P; Brown DC; Dewar JA; Thompson AM; Evans A
    Eur J Surg Oncol; 2014 Feb; 40(2):163-7. PubMed ID: 24332581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.
    Vaidya A; Vaidya P; Both B; Brew-Graves C; Bulsara M; Vaidya JS
    BMJ Open; 2017 Aug; 7(8):e014944. PubMed ID: 28819067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative radiotherapy in early breast cancer.
    Esposito E; Anninga B; Harris S; Capasso I; D'Aiuto M; Rinaldo M; Douek M
    Br J Surg; 2015 May; 102(6):599-610. PubMed ID: 25787293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative exploration of patients' experiences with Intrabeam TARGeted Intraoperative radioTherapy (TARGIT-IORT) and External-Beam RadioTherapy Treatment (EBRT) for breast cancer.
    Bagga SK; Swiderska N; Hooker C; Royle J; Ennis-O'Connor M; Freeney S; Watson D; Woolcock R; Lodge G; Laws S; Vaidya JS
    BMJ Open; 2024 Aug; 14(8):e081222. PubMed ID: 39164104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
    Welzel G; Boch A; Sperk E; Hofmann F; Kraus-Tiefenbacher U; Gerhardt A; Suetterlin M; Wenz F
    Radiat Oncol; 2013 Jan; 8():9. PubMed ID: 23294485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option?
    Shah C; Badiyan S; Khwaja S; Shah H; Chitalia A; Nanavati A; Kundu N; Vaka V; Lanni TB; Vicini FA
    Clin Breast Cancer; 2014 Apr; 14(2):141-6. PubMed ID: 24291378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of intraoperative radiotherapy in early breast cancer.
    Cuncins-Hearn A; Saunders C; Walsh D; Borg M; Buckingham J; Frizelle F; Maddern G
    Breast Cancer Res Treat; 2004 Jun; 85(3):271-80. PubMed ID: 15111766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
    Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
    Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation.
    Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS
    Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-step intraoperative radiotherapy optimizes conservative treatment of breast cancer with advantages in quality of life and work resumption.
    Sorrentino L; Fissi S; Meaglia I; Bossi D; Caserini O; Mazzucchelli S; Truffi M; Albasini S; Tabarelli P; Liotta M; Ivaldi GB; Corsi F
    Breast; 2018 Jun; 39():123-130. PubMed ID: 29674010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient preferences for adjuvant radiotherapy in early breast cancer are strongly influenced by treatment received through random assignment.
    Corica T; Saunders CM; Bulsara MK; Taylor M; Joseph DJ; Nowak AK
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12985. PubMed ID: 30637839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
    Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer.
    Hashemi S; Javadi S; Akbari ME; Mirzaei H; Mahdavi SR
    Int J Surg Oncol; 2021; 2021():2476527. PubMed ID: 33953982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Firs Case Report of Intraoperative Radiotherapy (IORT) for Early Breast Cancer in Bulgaria].
    Sedloev T; Gabrovski I; Usheva S; Kovacheva S; Spiridonova T; Spirdonov J; Jeleva Z; Terziev I; Korukov B; Damyanov D; Lövey G
    Khirurgiia (Sofiia); 2016; 82(1):40-4. PubMed ID: 29383929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the use of intraoperative radiotherapy on costs, travel time and distance for women with breast cancer in the Mexico City Metropolitan Area.
    Bargallo-Rocha JE; Soto-Perez-de-Celis E; Picó-Guzmán FJ; Quintero-Rodríguez CE; Almog D; Santiago-Concha G; Flores-Balcazar CH; Corona J; Vazquez-Romo R; Villarreal-Garza C; Mohar A
    J Surg Oncol; 2017 Nov; 116(6):683-689. PubMed ID: 28608393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.